This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Out of public health concerns and given the current travel restrictions and lab closures worldwide because of COVID-19, the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada has been postponed to July 6 - 9, 2021 and will now be delivered Virtually.

Speakers

James_Trevaskis.jpg

James Trevaskis

Senior Director, Biology - Head Fibrosis Research
Gilead
USA

 Jim Trevaskis currently heads the Fibrosis Biology research team at Gilead, leading internal drug development programs and external collaborations in the areas of NASH, PSC, fibrotic lung diseases and diabetic kidney disease. He has extensive prior experience as project team leader and pharmacologist in diabetes and obesity research programs at MedImmune/AstraZeneca, Novartis and Amylin Pharmaceuticals. Jim is expert in the application of combination strategies for metabolic diseases such as obesity and NASH.